KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:可得 入排置信度 0.98

Reduction in Dressing Change Burden in Patients With Epidermolysis Bullosa-Impact of Oleogel-S10.

Anna L Bruckner, Dédée Murrell, Lara Wine Lee, Eli Sprecher, Dimitra Kiritsi, Laura Maher, Sandra Löwe, Maryanne Donovan, Johannes S Kern, EASE investigators

J Dermatol 52(9) 1447-1451

PMID40908727
PMCIDPMC12411827
DOI10.1111/1346-8138.17884
发表日期2025-09-05
入排依据:未发现恶性肿瘤人群证据。
已检查 3 张 PubMed Figure,均未识别为 KM 图:FIGURE 1:森林图/亚组分析图;FIGURE 2:森林图/亚组分析图;FIGURE 3:森林图/亚组分析图。
摘要

摘要

Epidermolysis bullosa (EB) is a severe genetic disorder marked by skin fragility and blistering from minimal trauma. Management relies on frequent and painful dressing changes. The EASE study (NCT03068780), the largest to date in EB, previously demonstrated accelerated wound healing and reduced wound burden for Oleogel-S10 (birch triterpenes) versus control gel. This post hoc analysis focused on dressing change frequency and related time and cost savings among patients with daily dressing changes at baseline (Oleogel-S10 n = 47, control gel n = 53). By Day 90, 35.6% of Oleogel-S10 patients required fewer daily changes versus 10.6% in the control group (p = 0.005). Weekly dressing changes reduced by 1.36 ± 0.24 with Oleogel-S10 compared to 0.41 ± 0.23 for control (difference -0.95 ± 0.33; p = 0.005). This translated to almost three fewer dressing changes every 2 weeks for Oleogel-S10 versus nearly one change for the control gel. The estimated time saved per week was 10.7 h with Oleogel-S10 (6.4 h patient, 4.3 h caregiver) versus 4.0 h with control (2.4 h patient, 1.6 h caregiver). Estimated dressing costs reduced by 59%, from $63.4 k to $25.9 k per patient over 27 months. Oleogel-S10 significantly reduced dressing frequency and time burden, with potential to ease the intensive demands of EB wound care.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。
其他 Figure(3,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

FIGURE 1FIGURE 1 Changes from baseline in weekly frequency of dressing changes in the subgroup of patients with daily dressing changes at baseline in the EASE trial. Values represent LSM change in weekly frequency (±SE) of dressing changes in patients receiving daily dressing changes at baseline.
非 KM Figure
FIGURE 2FIGURE 2 Reduction in time required for dressing changes by patient and visit (A) and ‘Estimation of total time saved from baseline by patient at Day 90 (B) in the subgroup of patients with daily dressing changes at baseline in the EASE trial. (A) Graphed values represent reduction in time spent per day per patient for patients receiving Oleogel‐S10 versus control gel. (B) Derivation of values using the difference in hours spent on daily changes between baseline and Day 90. Total hours spent are divided by the number of patients with daily changes to obtain the hours spent per day per patient. This value is multiplied by 7 days to obtain weekly values for time spent, and a calculation is applied using data from Bruckner et al. [2] that suggests that for every hour spent by patients, an additional 66.7% is spent by caregivers. *66.7% of patients require assistance with dressing changes Bruckner et al. [2] LSM, least squares mean; SE, standard error of the mean.
非 KM Figure
FIGURE 3FIGURE 3 Costs saved on dressing changes: Derived from EASE data over 27 months. Data derived from the subgroup of patients requiring daily dressing changes at baseline. *The total cost of dressing changes for untreated patients calculated by multiplying by the cost of dressings required to cover the BSAP of all patients with daily dressing changes at Baseline for the treatment duration for DBP (91 days) and OLP (2 years). Unit costs in America (US dollars) for Mepitel were used to estimate dressing costs. (Mepitel was one of a small number of dressings that were recommended in EASE to reduce the diversity of wound dressings as much as possible; however, not all patients in EASE used Mepitel dressings). BSAP, body surface area percentage; DBP; double‐blind phase; k thousand; OLP, open‐label phase.
非 KM Figure